Wider fibrate use urged in mild to moderate CKD

Fibrates improve lipid profiles and reduce cardiovascular events and CV deaths in those with mild to moderate chronic kidney disease, according to a new meta-analysis. The authors are urging broader use of these agents in kidney patients.

via The Heart